A. Paul

发表

Evaluation of bleomycin, chlorozotocin, MGBG, and bruceantin in patients with advanced soft tissue sarcoma, bone sarcoma, or mesothelioma

David A. Amato, E. Borden, H. Enterline, 2004, Investigational New Drugs.

Phase III study of ICRF-159 versus 5-FU in the treatment of advanced metastatic colorectal carcinoma.

P. Engstrom, A. Paul, R. Catalano, 1980, Cancer treatment reports.

Phase II trial of razoxane (ICRF-159) in patients with squamous cell carcinoma of the head and neck previously exposed to systemic chemotherapy.

M. Shah, P. Engstrom, R. Creech, 1982, Cancer treatment reports.

Combined radiation and chemotherapy as primary management of adenocarcinoma of the esophagus and gastroesophageal junction

P. Engstrom, L. Coia, A. Paul, 1988, Cancer.

Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum

B. Eisenberg, L. Solin, L. Weiner, 1994 .

Phase II study of biochemical modulation of fluorouracil by low-dose PALA in patients with colorectal cancer.

S. Litwin, L. Weiner, P. O'dwyer, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma.

P. Engstrom, L. Coia, G. Hanks, 1991, International journal of radiation oncology, biology, physics.

Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A phase II study

B. Eisenberg, L. Solin, P. Engstrom, 1993, Cancer.

Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy.

P. Engstrom, L. Coia, A. Paul, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Use of Infusional 5-Fluorouracil, Mitomycin C, and Radiation as the Primary Management of Esophageal Cancer

P. Engstrom, L. Coia, G. Hanks, 1991 .

Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.

B. Eisenberg, L. Solin, L. Weiner, 1993, International journal of radiation oncology, biology, physics.

A single institutional experience with preoperative chemoradiotherapy for stage I-III pancreatic adenocarcinoma.

B. Eisenberg, L. Solin, P. Engstrom, 1993, The American surgeon.

Phase II Trial of Trastuzumab in Women with Advanced or Recurrent , HER 2-Positive Endometrial Carcinoma : a Gynecologic Oncology Group Study

J. Berek, J. Fiorica, G. Fleming, 2010 .

Increased resectability of locally advanced pancreatic and periampullary carcinoma with neoadjuvant chemoradiotherapy

L. Solin, J. Hoffman, J. Weese, 1990, International journal of pancreatology : official journal of the International Association of Pancreatology.

Treatment of advanced measurable or evaluable pancreatic carcinoma with 17-1A murine monoclonal antibody alone or in combination with 5-fluorouracil, adriamycin and mitomycin (FAM).

P. Engstrom, L. Weiner, H. Koprowski, 1986, Hybridoma.

An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277).

P. Lavin, A. Paul, H. Douglass, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II evaluation of dibromodulcitol, ICRF‐159, and maytansine for sarcomas

E. Borden, H. Enterline, H. Lerner, 1982, American journal of clinical oncology.

Management of esophageal cancer.

P. Engstrom, L. Coia, G. Hanks, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.